GE HealthCare (GEHC) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2024, GE HealthCare Technologies (GEHC) reported revenue of $5.32 billion, up 2.2% over the same period last year. EPS came in at $1.45, compared to $1.18 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $5.33 billion, representing a surprise of -0.25%. The company delivered an EPS surprise of +15.08%, with the consensus EPS estimate being $1.26.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how GE HealthCare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Imaging: $2.39 billion versus the four-analyst average estimate of $2.42 billion. The reported number represents a year-over-year change of -15.4%. Revenues- Other: $13 million compared to the $11.24 million average estimate based on four analysts. The reported number represents a change of -7.1% year over year. Revenues- PDx: $646 million compared to the $631.89 million average estimate based on four analysts. The reported number represents a change of +9.3% year over year. Revenues- PCS: $827 million versus the four-analyst average estimate of $863.16 million. The reported number represents a year-over-year change of 0%. View all Key Company Metrics for GE HealthCare here>>>Shares of GE HealthCare have returned +2.7% over the past month versus the Zacks S&P 500 composite's +3.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GE HealthCare Technologies Inc. (GEHC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks